These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 19914635)
1. Lack of effects of oral probiotics on growth and neurodevelopmental outcomes in preterm very low birth weight infants. Chou IC; Kuo HT; Chang JS; Wu SF; Chiu HY; Su BH; Lin HC J Pediatr; 2010 Mar; 156(3):393-6. PubMed ID: 19914635 [TBL] [Abstract][Full Text] [Related]
2. Do oral probiotics affect growth and neurodevelopmental outcomes in very low-birth-weight preterm infants? Sari FN; Eras Z; Dizdar EA; Erdeve O; Oguz SS; Uras N; Dilmen U Am J Perinatol; 2012 Sep; 29(8):579-86. PubMed ID: 22566113 [TBL] [Abstract][Full Text] [Related]
3. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Lin HC; Hsu CH; Chen HL; Chung MY; Hsu JF; Lien RI; Tsao LY; Chen CH; Su BH Pediatrics; 2008 Oct; 122(4):693-700. PubMed ID: 18829790 [TBL] [Abstract][Full Text] [Related]
5. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Lin HC; Su BH; Chen AC; Lin TW; Tsai CH; Yeh TF; Oh W Pediatrics; 2005 Jan; 115(1):1-4. PubMed ID: 15629973 [TBL] [Abstract][Full Text] [Related]
6. Does necrotising enterocolitis impact the neurodevelopmental and growth outcomes in preterm infants with birthweight < or =1250 g? Soraisham AS; Amin HJ; Al-Hindi MY; Singhal N; Sauve RS J Paediatr Child Health; 2006 Sep; 42(9):499-504. PubMed ID: 16925534 [TBL] [Abstract][Full Text] [Related]
8. Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron. Ohls RK; Ehrenkranz RA; Das A; Dusick AM; Yolton K; Romano E; Delaney-Black V; Papile LA; Simon NP; Steichen JJ; Lee KG; Pediatrics; 2004 Nov; 114(5):1287-91. PubMed ID: 15520109 [TBL] [Abstract][Full Text] [Related]
9. Impact of oral probiotics on neurodevelopmental outcomes in preterm infants. Akar M; Eras Z; Oncel MY; Arayici S; Guzoglu N; Canpolat FE; Uras N; Oguz SS J Matern Fetal Neonatal Med; 2017 Feb; 30(4):411-415. PubMed ID: 27045204 [TBL] [Abstract][Full Text] [Related]
10. Oral probiotics: Lactobacillus sporogenes for prevention of necrotizing enterocolitis in very low-birth weight infants: a randomized, controlled trial. Sari FN; Dizdar EA; Oguz S; Erdeve O; Uras N; Dilmen U Eur J Clin Nutr; 2011 Apr; 65(4):434-9. PubMed ID: 21245887 [TBL] [Abstract][Full Text] [Related]
11. Necrotizing enterocolitis and neurodevelopmental outcome in extremely low birth weight infants <1000 g. Salhab WA; Perlman JM; Silver L; Sue Broyles R J Perinatol; 2004 Sep; 24(9):534-40. PubMed ID: 15254558 [TBL] [Abstract][Full Text] [Related]
12. Growth, efficacy, and safety of feeding an iron-fortified human milk fortifier. Berseth CL; Van Aerde JE; Gross S; Stolz SI; Harris CL; Hansen JW Pediatrics; 2004 Dec; 114(6):e699-706. PubMed ID: 15545616 [TBL] [Abstract][Full Text] [Related]
13. Cytokine levels in neonatal necrotizing enterocolitis and long-term growth and neurodevelopment. Lodha A; Asztalos E; Moore AM Acta Paediatr; 2010 Mar; 99(3):338-43. PubMed ID: 19922507 [TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18 months of age. Vohr BR; Poindexter BB; Dusick AM; McKinley LT; Wright LL; Langer JC; Poole WK; Pediatrics; 2006 Jul; 118(1):e115-23. PubMed ID: 16818526 [TBL] [Abstract][Full Text] [Related]
15. The association of growth impairment with neurodevelopmental outcome at eight years of age in very preterm children. Kan E; Roberts G; Anderson PJ; Doyle LW; Early Hum Dev; 2008 Jun; 84(6):409-16. PubMed ID: 18096332 [TBL] [Abstract][Full Text] [Related]
16. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. Bin-Nun A; Bromiker R; Wilschanski M; Kaplan M; Rudensky B; Caplan M; Hammerman C J Pediatr; 2005 Aug; 147(2):192-6. PubMed ID: 16126048 [TBL] [Abstract][Full Text] [Related]
17. Neurodevelopmental outcomes of very low-birth-weight infants after enteral glutamine supplementation in the neonatal period. van Zwol A; van den Berg A; Huisman J; Vermeulen RJ; Fetter WP; Twisk JW; van Elburg RM Acta Paediatr; 2008 May; 97(5):562-7. PubMed ID: 18394100 [TBL] [Abstract][Full Text] [Related]
18. Major congenital anomalies place extremely low birth weight infants at higher risk for poor growth and developmental outcomes. Walden RV; Taylor SC; Hansen NI; Poole WK; Stoll BJ; Abuelo D; Vohr BR; Pediatrics; 2007 Dec; 120(6):e1512-9. PubMed ID: 17984212 [TBL] [Abstract][Full Text] [Related]
19. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials. Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G; Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176 [TBL] [Abstract][Full Text] [Related]
20. A neurobehavioral intervention and assessment program in very low birth weight infants: outcome at 24 months. Koldewijn K; van Wassenaer A; Wolf MJ; Meijssen D; Houtzager B; Beelen A; Kok J; Nollet F J Pediatr; 2010 Mar; 156(3):359-65. PubMed ID: 19880139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]